Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3992015 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| Houttuynin SCHEMBL1144900 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL3987687 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| 3-Oxotetradecanal SCHEMBL1301744 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL3992626 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL3986013 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL3993688 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL3990464 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| 3-Oxodecanal SCHEMBL3646476 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 | |
| SCHEMBL3987323 | 1.00 | KMT2A (0.56) | KMT2AMAPTCES2CES1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108929400-B | Nickel catalyst system, high-performance polybutadiene and preparation method thereof | 北京化工大学 | 2023-03-14 | — | — | CN | claimed |
| CN-1297260-C | Fatty acyl acetaldehyde powder projection and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2007-01-31 | — | — | CN | claimed |
| CN-1647795-A | Fatty acyl acetaldehyde transfusion preparation and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2005-08-03 | — | — | CN | claimed |
| CN-1647794-A | Fatty acyl acetaldehyde powder projection and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2005-08-03 | — | — | CN | claimed |
| US-7537906-B2 | Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone | Nomura, Nobuhiko (JP) | 2009-05-26 | — | — | US | disclosed |
| US-7527963-B2 | Acetyl-CoA acyltransferase gene disrupted bacterium for producing polyhydroxyalkanoate and method for producing polyhydroxyalkanoate using the same | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| CN-1297261-C | Fatty acyl acetaldehyde transfusion preparation and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2007-01-31 | — | — | CN | disclosed |
| CN-1297260-C | Fatty acyl acetaldehyde powder projection and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2007-01-31 | — | — | CN | disclosed |
| US-20060172399-A1 | Acetyl-CoA acyltransferase gene disrupted bacterium for producing polyhydroxyalkanoate and method for producing polyhydroxyalkanoate using the same | CANON KABUSHIKI KAISHA (JP) | 2006-08-03 | — | — | US | disclosed |
| CN-1647795-A | Fatty acyl acetaldehyde transfusion preparation and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2005-08-03 | — | — | CN | disclosed |
| CN-1647794-A | Fatty acyl acetaldehyde powder projection and its preparing method | ZIJIAN BIOLOG TECHNOLOGY CO LT (CN) | 2005-08-03 | — | — | CN | disclosed |
| US-20040229944-A1 | Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone | NIPPON SHOKUBAI CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| EP-1442742-A1 | Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone | Nomura, Nobuhiko (JP) | 2004-08-04 | — | — | EP | disclosed |
| US-4125517-A | ULTRAVIOLET RADIATION | CIBA-GEIGY CORPORATION (US) | 1978-11-14 | — | — | US | disclosed |
| US-4051137-A | Substituted piperazine diones and polymeric compositions stabilized thereby | CIBA-GEIGY CORPORATION (US) | 1977-09-27 | — | — | US | disclosed |
| US-3968078-A | Alkyl alkanoate derivatives of substituted piperazine-diones and polymer compositions stabilized thereby | CIBA-GEIGY CORPORATION (US) | 1976-07-06 | — | — | US | disclosed |
| US-3936456-A | Substituted piperazine dione oxyls and hydroxides and polymer compositions stabilized thereby | CIBY-GEIGY CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229944-A1 | Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone | API5, BAX, AKT1S1 | KMT2A 4455/4885MAPT 4806/4885CES2 2285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.